dexmedetomidine has been researched along with Brain Hemorrhage, Cerebral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, G | 1 |
| Gong, HS; Li, JY; Liu, MJ; You, YQ; Zhao, XC | 1 |
| Chen, P; Chen, W; Dong, R; Li, F; Maegele, M; Xu, Y; Yang, H | 1 |
| Huang, J; Jiang, Q | 1 |
| Song, HL; Zhang, SB | 1 |
| Choi, IY; Chung, JY; Hwang, L; Jin, JJ; Kim, CJ; Kim, SE; Kim, SH; Ko, IG; Shin, MS; Yi, JW | 1 |
1 trial(s) available for dexmedetomidine and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Safety and efficacy of applying sufficient analgesia combined with a minimal sedation program as an early antihypertensive treatment for spontaneous intracerebral hemorrhage: a randomized controlled trial.
Topics: Analgesia; Antihypertensive Agents; Cerebral Hemorrhage; Clinical Trials Data Monitoring Committees; Conscious Sedation; Data Interpretation, Statistical; Dexmedetomidine; Humans; Hypertension; Outcome Assessment, Health Care; Pharmacovigilance; Prospective Studies; Remifentanil; Sample Size; Single-Blind Method | 2018 |
5 other study(ies) available for dexmedetomidine and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Dexmedetomidine inhibits cerebral nerve cell apoptosis after cerebral hemorrhage in rats via the Nrf2/HO-1/NQO1 signaling pathway.
Topics: Animals; Apoptosis; Cerebral Hemorrhage; Dexmedetomidine; Heme Oxygenase-1; Humans; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Superoxide Dismutase; Water | 2022 |
Dexmedetomidine prevents hemorrhagic brain injury by reducing damage induced by ferroptosis in mice.
Topics: Animals; Brain Injuries; Cerebral Hemorrhage; Dexmedetomidine; Ferroptosis; Iron; Mice; Reactive Oxygen Species | 2022 |
Dexmedetomidine Protects Against Neurological Dysfunction in a Mouse Intracerebral Hemorrhage Model by Inhibiting Mitochondrial Dysfunction-Derived Oxidative Stress.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Behavior, Animal; Brain; Cerebral Hemorrhage; Dexmedetomidine; Disease Models, Animal; Male; Maze Learning; Mice, Inbred C57BL; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Superoxide Dismutase; Uncoupling Protein 2 | 2019 |
Therapeutic effect of dexmedetomidine on intracerebral hemorrhage via regulating NLRP3.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Dexmedetomidine; Down-Regulation; Gene Expression Regulation; Inflammasomes; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Random Allocation | 2019 |
Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus.
Topics: Animals; Apoptosis; Avoidance Learning; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Caspase 3; Cerebral Hemorrhage; Dexmedetomidine; DNA Fragmentation; In Situ Nick-End Labeling; Maze Learning; Memory Disorders; Memory, Short-Term; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptor, trkB | 2013 |